|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar
|
|
2
|
Rasheed SAK, Teo CR, Beillard EJ,
Voorhoeve PM and Casey PJ: MicroRNA-182 and microRNA-200a control
G-protein subunit α-13 (GNA13) expression and cell invasion
synergistically in prostate cancer cells. J Biol Chem.
288:7986–7995. 2013.PubMed/NCBI
|
|
3
|
Xiang B, Wang W, Li W, Li X, Li X and Li
G: Differential expression of oxidored nitro domain containing
protein 1 (NOR1), in mouse tissues and in normal and cancerous
human tissues. Gene. 493:18–26. 2012. View Article : Google Scholar
|
|
4
|
Li W, Li X, Wang W, et al: NOR1 is an
HSF1-and NRF1-regulated putative tumor suppressor inactivated by
promoter hypermethylation in nasopharyngeal carcinoma.
Carcinogenesis. 32:1305–1314. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ouyang J, Wu M, Huang C, Cao L and Li G:
Overexpression of oxidored-nitro domain containing protein 1
inhibits human nasopharyngeal carcinoma and cervical cancer cell
proliferation and induces apoptosis: Involvement of mitochondrial
apoptotic pathways. Oncol Rep. 29:79–86. 2013.
|
|
6
|
Nie X, Zhang B, Li X, et al: Cloning,
expression, and mutation analysis of NOR1, a novel human gene
down-regulated in HNE1 nasopharyngeal carcinoma cell line. J Cancer
Res Clin Oncol. 129:410–414. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kroeger H, Jelinek J, Estécio MR, et al:
Aberrant CpG island methylation in acute myeloid leukemia is
accentuated at relapse. Blood. 112:1366–1373. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gui R, Liu J, Li D, Tang H, Feng Z and Nie
X: NOR1 enhanced CB1954 induced cell cytotoxicity in HepG2 is
dependent on Grb2 mediated MAPK pathway. In: Bioinformatics and
Biomedical Engineering (iCBBE), 2010 4th International Conference
on IEEE; pp. 1–7. 2010
|
|
9
|
Shen L, Kantarjian H, Guo Y, et al: DNA
methylation predicts survival and response to therapy in patients
with myelodysplastic syndromes. J Clin Oncol. 28:605–613. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jelinek J, Gharibyan V, Estecio MR, et al:
Aberrant DNA methylation is associated with disease progression,
resistance to imatinib and shortened survival in chronic
myelogenous leukemia. PloS One. 6:e221102011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brentnall M, Rodriguez-Menacol L, De
Guevara RL, Cepero E and Boise LH: Caspase-9, caspase-3 and
caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell
Biol. 14:322013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kuribayashi K, Finnberg NK, Jeffers JR,
Zambetti GP and El-Deiry WS: The relative contribution of
pro-apoptotic p53-target genes in the triggering of apoptosis
following DNA damage in vitro and in vivo. Cell Cycle.
10:2380–2389. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
D’Sa-Eipper C, Leonard JR, Putcha G, et
al: DNA damage-induced neural precursor cell apoptosis requires p53
and caspase 9 but neither Bax nor caspase 3. Development.
128:137–146. 2001.PubMed/NCBI
|
|
14
|
Porter AG and Jänicke RU: Emerging roles
of caspase-3 in apoptosis. Cell Death Differ. 6:99–104. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Boucher MJ, Morisset J, Vachon PH, Reed
JC, Lainé J and Rivard N: MEK/ERK signaling pathway regulates the
expression of Bcl-2, Bcl-XL, and Mcl-1 and promotes survival of
human pancreatic cancer cells. J Cell Biochem. 79:355–369. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wei MC, Zong WX, Cheng EHY, et al:
Proapoptotic BAX and BAK: a requisite gateway to mitochondrial
dysfunction and death. Science. 292:727–730. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kobayashi Y, Shibusawa A, Saito H, et al:
Isolation and functional characterization of a novel organic solute
carrier protein, hOSCP1. J Biol Chem. 280:32332–32339. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin JG, Chen GW, Li TM, Chouh ST, Tan TW
and Chung JG: Aloe-emodin induces apoptosis in T24 human bladder
cancer cells through the p53 dependent apoptotic pathway. J Urol.
175:343–347. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Trotta AP, Need EF, Selth LA, et al:
Knockdown of the cochaperone SGTA results in the suppression of
androgen and PI3K/Akt signaling and inhibition of prostate cancer
cell proliferation. Int J Cancer. 133:2812–2823. 2013.PubMed/NCBI
|
|
20
|
Zhao D, Lin F, Wu X, et al: Pseudolaric
acid B induces apoptosis via proteasome-mediated Bcl-2 degradation
in hormone-refractory prostate cancer DU145 cells. Toxicol In
Vitro. 26:595–602. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu Y, Zhang SP and Cai YQ: Cytoprotective
effects of selenium on cadmium-induced LLC-PK1 cells apoptosis by
activating JNK pathway. Toxicol In Vitro. 21:677–684. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tucci P, Agostini M, Grespi F, et al: Loss
of p63 and its microRNA-205 target results in enhanced cell
migration and metastasis in prostate cancer. Proc Natl Acad Sci
USA. 109:15312–15317. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak K and Schmittgen T: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (-Delta Delta C (T) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kato T, Fujita Y, Nakane K, et al: ETS1
promotes chemoresistance and invasion of paclitaxel-resistant,
hormone-refractory PC3 prostate cancer cells by up-regulating MDR1
and MMP9 expression. Biochem Biophys Res Commun. 417:966–971. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tanaka H, Kono E, Tran CP, et al:
Monoclonal antibody targeting of N-cadherin inhibits prostate
cancer growth, metastasis and castration resistance. Nat Med.
16:1414–1420. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Aghaei M, Karami-Tehrani F, Panjehpour M,
Salami S and Fallahian F: Adenosine induces cell-cycle arrest and
apoptosis in androgen-dependent and -independent prostate cancer
cell lines, LNcap-FGC-10, DU-145, and PC3. Prostate. 72:361–375.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu X, Gao X, Jin L, et al:
Antiproliferation and cell apoptosis inducing bioactivities of
constituents from Dysosma versipellis in PC3 and Bcap-37
cell lines. Cell Div. 6:142011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
De Zutter GS and Davis RJ: Pro-apoptotic
gene expression mediated by the p38 mitogen-activated protein
kinase signal transduction pathway. Proc Natl Acad Sci USA.
98:6168–6173. 2001.
|
|
29
|
Murillo H, Schmidt LJ and Tindall DJ:
Tyrphostin AG825 triggers p38 mitogen-activated protein
kinase-dependent apoptosis in androgen-independent prostate cancer
cells C4 and C4-2. Cancer Res. 61:7408–7412. 2001.PubMed/NCBI
|
|
30
|
Tanaka Y, Gavrielides MV, Mitsuuchi Y,
Fujii T and Kazanietz MG: Protein kinase C promotes apoptosis in
LNCaP prostate cancer cells through activation of p38 MAPK and
inhibition of the Akt survival pathway. J Biol Chem.
278:33753–33762. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Marsden VS, O’Connor L, O’Reilly LA, et
al: Apoptosis initiated by Bcl-2-regulated caspase activation
independently of the cytochrome c/Apaf-1/caspase-9 apoptosome.
Nature. 419:634–637. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cory S and Adams JM: The Bcl2 family:
regulators of the cellular life-or-death switch. Nat Rev Cancer.
2:647–656. 2002. View
Article : Google Scholar : PubMed/NCBI
|
